86618 (86618) Fair Value & Analysis
· Market cap 182B CNY
Fair value as of: Jul 3, 2026
From 24 valuation models · updated today
Share price −13.9% over the past month.
Price vs Fair Value (12 months)
12‑month range ¥27.86 – ¥63.75 · fair‑value band ¥11.14 – ¥18.56 · the ¥29.58 price screens above the ¥14.85 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
86618 (86618) currently trades at ¥29.58, while our model-based Fair Value estimate is ¥14.85 — implying the stock looks roughly 49.8% overvalued today. We read business quality at 60/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
Over the trailing twelve months, 86618 generated revenue of 73.4B CNY at a net margin of 7.3%. Revenue grew 28.0% year over year. It earns a return on equity of 9.3%. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
86618 reported revenue of ¥73.4B in FY2025 versus ¥46.7B in FY2022, a compound +16.3%/yr. Reported net income was ¥5.4B in FY2025, compounding +141.8%/yr from FY2022.
Is 86618 fairly valued? → Check now
Explore undervalued stocks
Frequently asked questions
Is 86618 (86618) undervalued?
What is the fair value of 86618?
What is the quality score of 86618?
What is the revenue of 86618 (86618)?
What is the net profit margin of 86618?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.